{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:29:34Z","timestamp":1783938574952,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,24]],"date-time":"2027-06-24T00:00:00Z","timestamp":1813795200000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA244100"],"award-info":[{"award-number":["U01CA244100"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030622","name":"UNC Department of Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009164","name":"Moffitt Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009164","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijrobp.2025.12.053","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:14:48Z","timestamp":1767888888000},"page":"1043-1050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Phase 2 Prospective Trial of Personalized Radiation Therapy Fractionation in Human Papillomavirus Positive Oropharyngeal Cancer"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6417-2483","authenticated-orcid":false,"given":"Jimmy J.","family":"Caudell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Echevarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngchul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedar","family":"Kirtane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Kish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameel","family":"Muzaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Enderling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.12.053_bib0001","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0003","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2015.08.033","article-title":"Phase 2 trial of de-intensified chemoradiation therapy for favorable-risk human papillomavirus\u2013associated oropharyngeal squamous cell carcinoma","volume":"93","author":"Chera","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0004","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijrobp.2019.08.038","article-title":"NRG-HN002: A randomized phase II trial for patients with p16-Positive, non-smoking-associated, locoregionally advanced oropharyngeal cancer","volume":"105","author":"Yom","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0005","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijrobp.2024.08.014","article-title":"Interim futility results of NRG-HN005, a randomized, phase II\/III non-inferiority trial for non-smoking p16+ oropharyngeal cancer patients","volume":"120","author":"Yom","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0006","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-19-0211","article-title":"Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-Associated oropharyngeal cancer","volume":"25","author":"Chera","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0007","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): A retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0008","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hed.26467","article-title":"Prognostic potential of mid-treatment nodal response in oropharyngeal squamous cell carcinoma","volume":"43","author":"Byun","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0009","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijrobp.2021.05.132","article-title":"Forecasting individual patient response to radiation therapy in head and neck cancer with a dynamic carrying capacity model","volume":"111","author":"Zahid","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.oraloncology.2016.10.022","article-title":"CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy","volume":"63","author":"Perni","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0011","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.3390\/curroncol29090495","article-title":"Changes in apparent diffusion coefficient (ADC) in serial weekly MRI during radiotherapy in patients with head and neck cancer: Results from the PREDICT-HN study","volume":"29","author":"Ng","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0012","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djaa184","article-title":"Precision radiotherapy: Reduction in radiation for oropharyngeal cancer in the 30 ROC trial","volume":"113","author":"Riaz","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0013","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13014-015-0465-x","article-title":"A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation","volume":"10","author":"Prokopiou","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0014","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s11538-017-0279-0","article-title":"Predicting patient-specific radiotherapy protocols based on mathematical model choice for proliferation saturation index","volume":"80","author":"Poleszczuk","year":"2018","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0015","first-page":"18","article-title":"Proliferation saturation index to characterize response to RT and evaluate altered fractionation in head and neck cancer","volume":"10","author":"Zahid","year":"2021","journal-title":"Appl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0360-3016(87)90258-6","volume":"13","author":"Marcial","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0017","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0360-3016(90)90054-N","article-title":"Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: Preliminary report of radiation therapy oncology group protocol 83-13","volume":"18","author":"Cox","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0018","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.radonc.2013.06.044","article-title":"Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity","volume":"109","author":"Nuyts","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.radonc.2016.08.009","article-title":"Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control","volume":"122","author":"Nevens","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.radonc.2017.03.003","article-title":"Recurrence patterns after a decreased dose of 40 Gy to the elective treated neck in head and neck cancer","volume":"123","author":"Nevens","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0021","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamaoncol.2023.1352","article-title":"Weekly adaptive radiotherapy vs standard intensity-modulated radiotherapy for improving salivary function in patients with head and neck cancer: A phase 3 randomized clinical trial","volume":"9","author":"Castelli","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0022","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2011.08.017","article-title":"Adaptive radiotherapy for head-and-neck cancer: Initial clinical outcomes from a prospective trial","volume":"83","author":"Schwartz","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0023","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1158\/1078-0432.CCR-22-1522","article-title":"Randomized phase II study of physiologic MRI-directed adaptive radiation boost in poor prognosis head and neck cancer","volume":"28","author":"Mierzwa","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.bjc.6600119","article-title":"Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: Influence of proliferation","volume":"86","author":"Awwad","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0026","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejca.2005.10.022","article-title":"Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapy","volume":"42","author":"Wilson","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2010.01.019","article-title":"A phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas (RTOG 0129): Report of efficacy and toxicity","volume":"77","author":"Ang","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0028","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis","volume":"18","author":"Lacas","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.053_bib0029","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(21)00347-8","article-title":"Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): A cohort-based pooled analysis","volume":"22","author":"Scott","year":"2021","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162600012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162600012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:26:21Z","timestamp":1782480381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162600012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S036030162600012X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.12.053","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 2 Prospective Trial of Personalized Radiation Therapy Fractionation in Human Papillomavirus Positive Oropharyngeal Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.12.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}